KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to 17.15%.

  • Bio-Rad Laboratories' EBIT Margin fell 258900.0% to 17.15% in Q4 2025 from the same period last year, while for Dec 2025 it was 1.83%, marking a year-over-year decrease of 86500.0%. This contributed to the annual value of 1.83% for FY2025, which is 86500.0% down from last year.
  • Bio-Rad Laboratories' EBIT Margin amounted to 17.15% in Q4 2025, which was down 258900.0% from 10.0% recorded in Q3 2025.
  • Bio-Rad Laboratories' EBIT Margin's 5-year high stood at 20.99% during Q3 2021, with a 5-year trough of 17.15% in Q4 2025.
  • Moreover, its 5-year median value for EBIT Margin was 13.89% (2022), whereas its average is 11.93%.
  • Its EBIT Margin has fluctuated over the past 5 years, first skyrocketed by 77900bps in 2021, then plummeted by -258900bps in 2025.
  • Over the past 5 years, Bio-Rad Laboratories' EBIT Margin (Quarter) stood at 16.09% in 2021, then rose by 1bps to 16.25% in 2022, then fell by -14bps to 13.99% in 2023, then tumbled by -38bps to 8.73% in 2024, then tumbled by -296bps to 17.15% in 2025.
  • Its EBIT Margin was 17.15% in Q4 2025, compared to 10.0% in Q3 2025 and 11.83% in Q2 2025.